Coverage 72 Secondary Research 72 Primary Research 72 Expert Panel Validation 72 Contact Us 72 Disclaimer 73
List of Tables Number of Products under Development for, H2 2016 9 Number of Products under Development by Therapy Area, H2 2016 10 Number of Products under Development by Indication, H2 2016 12 Comparative Analysis by Late Stage Development, H2 2016 13
Read Complete Report With TOC @ http:// www. radiantinsights. com / research / e3-ubiquitinprotein-ligase-mdm2
Comparative Analysis by Early Stage Products, H2 2016 14 Number of Products under Development by Companies, H2 2016 15 Products under Development by Companies, H2 2016 16 Products under Development by Companies, H2 2016( Contd.. 1) 17 Products under Development by Companies, H2 2016( Contd.. 2) 18 Number of Products under Investigation by Universities / Institutes, H2 2016 19 Products under Investigation by Universities / Institutes, H2 2016 20 Assessment by Monotherapy / Combination Products, H2 2016 21 Number of Products by Stage and Mechanism of Action, H2 2016 22
Number of Products by Stage and Route of Administration, H2 2016 24 Number of Products by Stage and Molecule Type, H2 2016 26 Pipeline by Aileron Therapeutics, Inc., H2 2016 27